| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |